A Study of Tirzepatide in Overweight and Very Overweight Participants

NCT04311411 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight

Interventions

DRUG: Tirzepatide
DRUG: Placebo
DRUG: Liraglutide

Sponsor

Eli Lilly and Company